| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 14 |
| 1 | METHOTREXATE | 14 |
| 2 | METHOTREXATE SODIUM | 14 |
| 3 | OMEPRAZOLE | 14 |
| 4 | OMEPRAZOLE MAGNESIUM | 14 |
| 5 | DOCETAXEL | 12 |
| 6 | DOCETAXEL ANHYDROUS | 12 |
| 7 | BUPRENORPHINE | 11 |
| 8 | RITUXIMAB | 11 |
| 9 | ALBUTEROL SULFATE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEMIN | 2 | 0.0034 |
| 1 | FROVATRIPTAN SUCCINATE | 2 | 0.0025 |
| 2 | METRELEPTIN | 2 | 0.0016 |
| 3 | METHENAMINE HIPPURATE | 2 | 0.0016 |
| 4 | RALTEGRAVIR | 8 | 0.0015 |
| 5 | DARUNAVIR 600 MG | 9 | 0.0015 |
| 6 | GIVOSIRAN SODIUM | 2 | 0.0013 |
| 7 | PRUCALOPRIDE | 3 | 0.0013 |
| 8 | SCOPOLAMINE | 4 | 0.0011 |
| 9 | DARUNAVIR | 9 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 23 |
| 1 | Platinum-based Drug [EPC] | 23 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 22 |
| 3 | Proton Pump Inhibitor [EPC] | 16 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 5 | GLP-1 Receptor Agonist [EPC] | 14 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 14 |
| 7 | Microtubule Inhibitor [EPC] | 13 |
| 8 | Benzodiazepine [EPC] | 11 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 1 | Leptin Analog [EPC] | 2 | 0.0016 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 5 | Cannabinoid [EPC] | 3 | 0.0004 |
| 6 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 7 | Chloride Channel Activator [EPC] | 3 | 0.0003 |
| 8 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 9 | Anticholinergic [EPC] | 4 | 0.0002 |